Wertzel H, Swoboda L, Joos-Würtemberger A, Frank U, Hasse J
Department of Pulmonary Surgery, University Hospital, Freiburg, Germany.
Thorac Cardiovasc Surg. 1992 Dec;40(6):326-9. doi: 10.1055/s-2007-1020174.
A prospective study of the efficacy of ampicillin in combination with sulbactam, a beta-lactamase inhibitor, (A/S) in perioperative prophylaxis was performed. The study consisted of two independent parts performed at the same time. Part I included 60 patients with lobectomies and segmentectomies. Group A (A/S 1 x 3 g "single shot") was compared with group B (A/S 3 x 3 g). Superficial wound infections occurred in 3 patients of group A and in 2 patients of group B. There was no empyema. Bronchitis and pneumonia were found in 10 patients of group A and in 7 patients of group B. Part II examined 25 pneumonectomies receiving A/S 3 x 3 g for 3 days. Concentrations of ampicillin and sulbactam in serum and lung tissue were determined and showed adequate levels to cope with usual bacteria in lung surgery. There was one superficial wound infection, 2 cases of bronchitis, and 2 cases of pneumonia.
开展了一项关于氨苄西林联合β-内酰胺酶抑制剂舒巴坦(A/S)用于围手术期预防效果的前瞻性研究。该研究由同时进行的两个独立部分组成。第一部分纳入60例行肺叶切除术和肺段切除术的患者。将A组(A/S 1×3 g“单次给药”)与B组(A/S 3×3 g)进行比较。A组有3例患者发生浅表伤口感染,B组有2例患者发生浅表伤口感染。未发生脓胸。A组有10例患者出现支气管炎和肺炎,B组有7例患者出现支气管炎和肺炎。第二部分检查了25例行肺切除术且接受A/S 3×3 g治疗3天的患者。测定了血清和肺组织中氨苄西林和舒巴坦的浓度,结果显示其水平足以应对肺部手术中常见的细菌。有1例浅表伤口感染、2例支气管炎和2例肺炎。